![A computer screen and an open book to suggest training materials](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_medium_no_crop/public/2023-07/ACT-EU_PA_clinical-trials-training-curriculum.png?itok=3LGpVE50)
ACT EU aims to provide a training curriculum informed by regulatory experience, with modules on drug development and regulatory science.
This curriculum is expected to engage universities and small and medium-sized enterprises, and serve as an educational ecosystem.
Related documents
A training strategy is available, setting out high-level objectives for the development of a training curriculum.
This document highlights the importance of accessing appropriate expertise in medicines development: